
Jounce Therapeutics JNCE
Annual report 2022
added 04-28-2023
Jounce Therapeutics DSO Ratio 2011-2026 | JNCE
Annual DSO Ratio Jounce Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 2.32 | 90.2 | 6.96 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90.2 | 2.32 | 33.2 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
173 | $ 3.55 | -0.42 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
22.1 | $ 3.25 | 3.83 % | $ 229 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 0.79 | 0.04 % | $ 4.31 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 6.52 | -1.66 % | $ 179 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
132 | $ 229.5 | -0.66 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.43 | -4.99 % | $ 8.25 B | ||
|
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Anika Therapeutics
ANIK
|
77.3 | $ 14.54 | 1.25 % | $ 213 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
BioCardia
BCDA
|
101 | $ 1.3 | 2.36 % | $ 27.5 M | ||
|
AVEO Pharmaceuticals
AVEO
|
47.5 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.59 | -1.79 % | $ 16.3 M | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M |